Clinical Trial: Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Post COVID-19 Condition
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ampligen® in Patients With Post-COVID Conditions
Brief Summary:
The purpose of this study is to assess the efficacy and safety of Ampligen® administered twice weekly by intravenous (IV) infusions in subjects experiencing the Post-COVID Condition of fatigue.
Read more